Calithera Biosciences (NASDAQ:CALA) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research report sent to investors on Wednesday morning. The firm issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Stock Performance

NASDAQ CALA opened at $0.00 on Wednesday. Calithera Biosciences has a 1 year low of $0.00 and a 1 year high of $0.12.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.